| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT07148180 | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in… | Acute Myeloid Leukaemia (AML) | Recruiting |
| Phase 1 | |||
| NCT05455294 | Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms | Myeloid Malignancy | Active, Not Recruiting |
| NCT07439211 | Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients… | Leukemia, Myeloid | Not Yet Recruiting |
| NCT03613532 | Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy… | Acute Myeloid Leukemia (AML) | Active, Not Recruiting |